Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Paget Disease, Extramammary × Imiquimod × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 6 Carcinoma, Basal Cell 4 Squamous Intraepithelial Lesions 2 HIV Infections 2 Condylomata Acuminata 2 Uterine Cervical Dysplasia 1 Precancerous Conditions 1 Patient Satisfaction 1 Papillomavirus Infections 1 Paget Disease, Extramammary 1 Hutchinson's Melanotic Freckle 1 Carcinoma, Squamous Cell 1 Anus Neoplasms 1 Acquired Immunodeficiency Syndrome 1

Interventions

Lidocaine 1 Imiquimod 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02385188 2020-01-02

Topical 5% Imiquimod Cream for Vulvar Paget's Disease

University Medical Center Nijmegen

Phase 3 Completed

Paget Disease, Extramammary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡